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a  b  s  t  r a  c t
Objective: The  effect of drugs other  than  alcohol  on severity  of trauma  remains  unclear.  Pooled  data
analyses  in previous studies  that  grouped  substances  with opposite  effects  on the  central  nervous  system
(CNS)  may  have  masked the  influence  of substances  on injury  severity. The aim  was  to analyze  the  effect  of
stimulant,  hallucinogenic  and depressant drugs  other  than  alcohol  on  injury  severity  in trauma  patients.
Methods: The presence  of alcohol,  stimulant  drugs (cocaine, amphetamines and  methamphetamines),
depressant  drugs (benzodiazepines,  opiates, methadone and barbiturates)  and  hallucinogenic drugs  (THC
and PCP) was analyzed  in 1187  patients between 16 and  70  years  old admitted to a  trauma  hospital
between November  2012  and June 2015.  Injury  severity  was  determined  prospectively as  the Injury
Severity Score.  A  multivariate  analysis  was used to quantify  the  strength  of association  between exposure
to substances and trauma  severity,  using the presence of alcohol  as  a  stratification  variable.
Results:  Drugs other  than alcohol were  found in 371 patients  (31.3%):  32 (2.7%)  stimulants, 186  (15.3%)
depressants,  78 (6.6%)  hallucinogenics  and 75  (5.6%) polydrug  use.  The presence of CNS depressant  sub-
stances was associated with increased  injury  severity  only in patients  also  exposed  to  alcohol,  with  an
adjusted odds  ratio  of 4.63  (1.37-15.60)  for moderate  injuries  and 7.83  (2.53-24.21) for  severe.
Conclusion:  CNS  depressant  drugs had a strong  influence  on injury severity  in patients who  screened
positive  for  alcohol consumption.
© 2017 SESPAS. Published by  Elsevier  España,  S.L.U. This is an open  access article  under  the  CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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r  e  s u  m e  n
Objetivo: No está  claro qué  efecto  tienen  las  drogas  distintas  del  alcohol  sobre la gravedad  de  los trau-
matismos.  Los análisis  incluidos  en estudios  previos, que agrupan  sustancias  con efectos opuestos  sobre
el  sistema  nervioso  central (SNC),  pueden  haber enmascarado la  influencia  de  estas  sobre la gravedad.  El
objetivo fue  analizar el  efecto  de  las  drogas alucinógenas,  estimulantes  y depresoras  del SNC,  diferentes
del  alcohol,  sobre la gravedad  de  las lesiones en  pacientes  ingresados por  traumatismos.
Métodos:  Se  analizó  la presencia  de  alcohol,  drogas estimulantes  (cocaína,  anfetaminas  y  metanfeta-
minas),  depresoras  (benzodiacepinas,  opiáceos, metadona y  barbitúricos)  y  alucinógenas  (THC  y  PCP) en
1187  pacientes de  entre 16  y  70 años  de  edad  ingresados por traumatismo  de  noviembre  de 2012 a  junio
de 2015.  La gravedad del  traumatismo se determinó  prospectivamente  mediante  la Injury  Severity Score.
Se  cuantificó  la  fuerza  de  la  asociación  entre  la exposición a sustancias  y  la gravedad del  traumatismo
mediante  un  análisis multivariante, utilizando  la  presencia  de  alcohol  como variable  de estratificación.
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Resultados: Se encontraron drogas diferentes del  alcohol  en  371  pacientes  (31,3%):  186  (15,3%)  depre-
soras,  78 (6,6%)  alucinógenas,  32  (2,7%) estimulantes  y  75  (5,6%)  combinadas.  La presencia  de  sustancias
depresoras  del SNC se asoció  con un aumento de  la gravedad  del  traumatismo  solo en  pacientes también
expuestos al alcohol,  con  una  odds ratio  ajustada  de  4,63  (1,37-15,6)  para  lesiones  moderadas  y  de  7,83
(2,53-24,21)  para lesiones  graves.
Conclusión:  Las  drogas  depresoras  del  SNC  tuvieron  una fuerte influencia  en  la gravedad  del  traumatismo
en  los pacientes  que además  presentaban resultados  positivos  para consumo  de  alcohol.
© 2017  SESPAS. Publicado por  Elsevier  España, S.L.U. Este  es  un  artı́culo Open  Access  bajo  la  licencia  CC
BY-NC-ND  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
The role of alcohol as a  major causal factor in trauma has
been highlighted in  several studies.1–5 In recent years concern has
spread to drugs other than alcohol,6–13,  including prescribed or
nonprescribed psychotropic drugs.14,15 Studies to date conclude
that exposure to  alcohol and drugs are  associated with a higher
risk of injury regardless of the mechanism of injury (traffic crashes,
falls, etc.).
Although there appears to be  agreement that alcohol and other
drugs are important risk factors for injury, there is no consensus
on the role of these substances in severity. Some studies found that
the  presence of these substances increases trauma severity,16–24
whereas others found no  such association.14,25–27 However, studies
that evaluated the effect of illicit or psychotropic drugs on trauma
rarely focused on the use of these substances separately,14,24,27
because the main focus of study was usually alcohol consumption.
This leads to important methodological deficiencies in  assessing
the association between substances other than alcohol and injury
severity. For example, drugs with different effects, including oppo-
site effects, on the central nervous system (CNS) are usually pooled
for statistical analysis.21–23,26 Moreover, some studies systemati-
cally excluded patients with positive tests for benzodiazepines and
opiates,21,24,26 because these drugs are frequently used in  prehos-
pital care for trauma patients. This makes it impossible to analyze
the role of these substances in  trauma severity. To these limita-
tions must be added the fact that these studies were frequently
based on data obtained from national, regional or hospital-based
trauma registries.16,19,21,22,27 These registries record only patients
whose medical care provider decided to  request an alcohol and/or
drug test at the time the patient was admitted to the emergency
room.
The factors related to  injury severity merit more in-depth anal-
ysis. Greater injury severity is strongly associated with increased
mortality, more complications, longer hospital stays, and ulti-
mately greater economic costs.28 We  believe it is worthwhile to
investigate the specific roles of drugs in  trauma severity, based
on the hypothesis that a separate analysis of the effect of each
substance on the CNS (depressants, stimulants and hallucinogens)
will indicate a  greater magnitude of association for the group of
depressant substances, due to the reduced awareness and impaired
cognitive and motor function that these agents cause.29 The aims
of the present study were thus to analyze the effect of stimulant,
hallucinogenic and depressant drugs other than alcohol on injury
severity in hospital patients admitted for trauma, and to determine
the possible role of alcohol as a  modifier of the effect of these drugs.
Methods
Environment
The data for this study were from a  cohort of patients admit-
ted for traumatic injuries. This cohort was created as part of a
Screening, Brief Intervention, and Referral to  Treatment (SBIRT)
project30 designed for trauma patients (MOTIVA project). The
MOTIVA project was approved by the Granada Provincial Research
Ethics Committee and was active during the 31 nonconsecu-
tive months during which it received financial support from the
Regional Andalusian Government and the Spanish National Traffic
Directorate: November 2011 to  October 2012, June 2013 to  Novem-
ber 2013, and June 2014 to  June 2015 at the University Hospital
Virgen de las Nieves of Granada, Spain. Our  Hospital is a  public
tertiary-care hospital with a separate trauma center that  covers a
population of more than 600,000 inhabitants.
Definition of exposure
The MOTIVA project involved screening for alcohol and drug
use in  all patients aged 16 to 70 years who were hospitalized for
trauma independently of trauma severity. Informed consent was
required before the screening. In sedated patients or  unable to col-
laborate, informed consent was  required when the clinical situation
was reversed or, if it was  not possible, to  relatives.
Screening for drugs (tetrahydrocannabinol [THC], phen-
cyclidine [PCP], cocaine, amphetamines, methamphetamines,
benzodiazepines, opiates, methadone, barbiturates or tricyclic
antidepressants) was  done with urine testing by fluorescence
immunoassay.31,32 Review of the patient’s medical record was used
to rule  out patients who tested positive for benzodiazepines and
opioids as a  result of emergency treatment of their injuries. Alcohol
consumption was  screened by blood testing, and was considered
positive when the blood alcohol level was higher than 0.3 g/L (the
same cutoff point established by the Spanish National Institute
of Toxicology and Forensic Sciences)33 at the time of  hospitaliza-
tion or, given the short window of detection (6 hours),34 if the
patient reported exposure on interview. Therefore, personal inter-
views were conducted to  confirm the status of alcohol exposure
in patients screened 6 hours after the trauma. The interviews were
carried out at the moment in which the patients’ clinical conditions
permitted it. The remaining study variables were collected from the
medical records prospectively.
Definition of outcome
The MOTIVA project contemplated the injury codification based
on the Abbreviated Injury Scale (AIS)35 of all  patients hospitalized
with injury diagnosis (ICD9-CM). This anatomical-based coding
system classifies injuries in  each of nine body regions using an ordi-
nal scale of 1-6, with 1 as least severe and 6 as most severe. For the
present study, trauma severity was measured with the Injury Sever-
ity Score (ISS).36 The ISS  is  determined by summing the squares of
the highest AIS rating (up to 5) for each of the three most severely
injured body areas. If any of the three scores is  a  6, the score is
automatically set at 75.  Consequently, ISS can take values between
1 and 75. Scores were recorded during the patient’s hospital stay.
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Table 1
Demographic and clinical comparisons according to substance(s) detected.
Group
Total
(n =  1187)
Negative




(n =  186)
Hallucinogen




Age, years, median (IQR) 43  (30-54) 44 (31-55) 30 (24-38) 51  (42-60) 26 (22-34) 44  (31-55) <0.001
Sex, n (%)
Male 825 (69.5) 575 (70.5) 28 (87.5) 83  (44.6) 73 (93.6) 66  (88.0) <0.001
Mechanism of injury, n (%)
Traffic collision 309 (26.0) 223 (27.3) 15 (46.9) 22  (11.8) 32 (41.0) 17  (22.7) <0.001
Sports injury 96  (8.1) 69 (8.5)  1 (3.1) 6 (3.2) 13 (16.7) 7  (9.3)
Assault  65  (5.5) 31 (3.8)  5 (15.6) 9 (4.8) 7 (9.0) 13  (17.3)
Falls  on the same level 361 (30.4) 257 (31.5) 3 (9.4) 86 (46.2) 7 (9.0) 8 (10.7)
Falls  from a height 164 (13.8) 105 (12.9) 1 (3.1) 33  (17.7) 7 (9.0) 18  (24.0)
Accidental cuts or bruises 126 (10.6) 91 (11.2) 7 (21.9) 14  (7.5) 8 (10.3) 6  (8.0)
Other  mechanisms 66  (5.6) 40 (4.9)  0 (0.0) 16  (8.6) 4 (5.1) 6  (8.0)
Alcohol  detected, n (%) 295 (24.9) 169 (20.7) 17 (53.1) 36  (19.4) 23 (29.5) 50 (66.7) <0.001
Injury Severity Score, n (%)
Mild: 1 to 8 820 (69.1) 577 (70.7) 24 (75.0) 124 (66.7) 50 (64.1) 45  (60.0) 0.529
Moderate: 9 to15 213 (17.9) 140 (17.2) 3 (9.4) 36  (19.4) 16 (20.5) 18  (24.0)
Severe:  ≥16 154 (13.0) 99 (12.1) 5 (15.6) 26 (14.0) 12 (15.4) 12  (16.0)
Hospital mortality, n (%) 23 (1.9) 17 (2.1)  1 (3.1) 3 (1.6) 1 (1.3) 1  (1.3) 0.921a
Days of hospitalization, median (IQR) 4 (2-9) 4 (3-9) 2 (1-9) 4 (2-8) 4 (2-12) 4  (1-11) 0.245
IQR: interquartile range.
a Chi-squared exact test.
Negatives: negative for drugs other than alcohol; Stimulant: positive for cocaine, amphetamines and/or methamphetamines; Depressants: positive for benzodiazepines,
opiates,  methadone and/or barbiturates; Hallucinogen: positive for THC and/or PCP; Polydrug: positive for any combination of substances in the above groups.
Analytic approach
The cases selected for this study were all screened patients from
the MOTIVA project. For the data analysis, the variable for the pres-
ence of drugs other than alcohol was categorized into five strata:
none, presence of CNS stimulant drugs (cocaine, amphetamines and
methamphetamines), presence of CNS depressant drugs (benzo-
diazepines, opiates, methadone and barbiturates), hallucinogenic
drugs (THC and PCP), and polydrug (any combination of substances
in the above groups). The ISS was categorized into three strata: mild
(1 to 8), moderate (9 to 15) and severe (≥16).
Continuous variables (age and days of hospital stay) are pre-
sented as medians with interquartile ranges. Between-group
comparisons of these variables were carried out with the Kruskal-
Wallis test. The chi-squared test was used to identify associations
between categorical variables (sex, mechanism of injury and hos-
pital mortality).
To quantify the strength of association between substance
consumption and trauma severity, we  used multinomial logistic
regression in two models. In all analyses, trauma severity was the
dependent variable and “mild” was used as the reference category.
In model 1 the presence of substances was categorized into the
five previously defined levels. The initial analysis was  done with
the entire sample, and in a second step, the sample was  stratified
according to the presence or absence of alcohol. In model 2 the same
statistical analyses were repeated but the presence of substances
was categorized dichotomously as presence or absence.
For both models, we  calculated crude odds ratios (cOR), and
adjusted odds ratio (aOR) estimates were obtained by  adding age,
sex, and mechanism of injury as independent variables. For all esti-
mates, we calculated the corresponding 95% confidence intervals
(95%CI). All analyses were done with the SPSS v. 20.0 for Windows
(SPSS, Chicago, IL, USA).
Results
Of all 1818 patients aged 16 to 70 years who were hospital-
ized for trauma during the study periods, 1187 (65.3%) could be
screened for alcohol and drug use; 609 patients were not screened
and 22 rejected it. Of all patients screened, 371 (31.3%) were posi-
tive for drugs other than alcohol: 32 (2.7%) for CNS stimulant drugs,
186 (15.7%) for CNS depressants, 78 (6.6%) for hallucinogenics and
75 (5.6%) for polydrug. Alcohol was the substance detected most
frequently (295 patients; 24.9%), followed by THC (144; 12.2%),
benzodiazepines (199; 16.8%), cocaine (81; 6.8%), opiates (26; 2.2%),
methadone (25; 2.1%); barbiturates (7; 0.6%), amphetamines (9;
0.8%) and PCP (2; 0.2%).
When we compared the demographic and clinical character-
istics of the five groups according to  type of drug consumed
(Table 1),  we found that age was  oldest for consumers of depres-
sant substances, with a median age (interquartile range) of
51 years (42-60), and much younger in patients who tested positive
for hallucinogenics (median: 26 years [22-34]). The proportion of
women was  greater in  the subgroup of individuals who tested pos-
itive for depressant drugs (44.6%) than in  the other four groups.
A  fall  on the same level was  the most frequent mechanism of
injury in  this group (46.2%), in contrast to the stimulant drugs
group, in which the most frequent mechanism was traffic crashes
(43.5%). In the subgroup of polydrug, alcohol consumption was
especially frequent (66.7%). There were no relevant differences
between groups in the duration of hospital stay (in days) or
mortality.
In the multivariate analysis (Table 2), the estimates of  strength
of association between each drug group and the frequency of
moderate and severe injuries in model 1 showed that alcohol
modified the association between depressant drugs and injury
severity. This association was nonexistent in the group who  had not
been exposed to alcohol, whereas alcohol consumption was  asso-
ciated with an increase in  injury severity in  the group of patients
exposed to CNS depressants, with an adjusted aOR of 4.63 (95%CI:
1.37-15.60) for moderate injuries and 7.83 (95%CI: 2.53-24.21) for
severe injuries. This modifying effect did not appear in  the other
groups.
In model 2 (Table 3), when pooled data were analyzed by group-
ing  drugs with opposite effects, no significant associations were
found in  the adjusted estimates.
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Table 2
Multivariate analysis of drugs detected and injury severity in the entire sample and by stratums positive or negative for alcohol. Model 1: substances other than alcohol
grouped according to  their effect on  the  central nervous system.
ISS moderate (9 to  15)a ISS  severe (≥16)a
cOR (95%CI) p aORb (95%CI) p cOR (95%CI) p  aORb (95%CI) p
Entire sample
Negatives 1.00 Ref. 1.00 Ref. 1.00 Ref. 1.00 Ref.
Stimulants 0.51 (0.15-1.73) 0.276  0.46 (0.13-1.66) 0.231 1.21 (0.45-3.26) 0.699 1.08 (0.38-3.06) 1.076
Depressants 1.20 (0.79-1.81) 0.396  1.47 (0.93-2.33) 0.099 1.22 (0.76-1.96) 0.406 1.68 (0.99-2.83) 0.054
Hallucinogenics 1.32 (0.73-2.38) 0.359  1.19 (0.63-2.25) 0.597 1.40 (0.72-2.72) 0.321 1.28 (0.62-2.63) 0.502
Polydrug 1.65 (0.92-2.93) 0.087  1.50 (0.81-2.80) 0.198 1.55 (0.79-3.04) 0.195 1.41 (0.69-2.91) 0.345
Stratum negative for alcohol
Negatives 1.00 Ref. 1.00 Ref. 1.00 Ref. 1.00 Ref.
Stimulants 0.37 (0.48-2.88) 0.323  0.34 (0.04-2.76) 0.316 1.22 (0.27-5.56) 0.799 1.30 (0.25-6.04) 0.800
Depressants 0.86 (0.53-1.42) 0.565  1.13 (0.66-1.93) 0.666 0.56 (0.27-1.15) 0.110 0.78 (0.36-1.70) 0.783
Hallucinogenics 1.78 (0.92-3.42) 0.082  1.67 (0.82-3.39) 0.158 1.25 (0.51-3.09) 0.624 1.23 (0.47-3.26) 0.669
Polydrug use 1.23 (0.45-3.39) 0.685  1.25 (0.44-3.57) 0.680 0.81 (0.18-3.58) 0.783 0.89 (0.19-4.14) 0.895
Stratum positive for alcohol
Negative 1.00 Ref. 1.00 Ref. 1.00 Ref. 1.00 Ref.
Stimulants 0.51 (0.11-2.42) 0.393  0.49 (0.09-2.64) 0.488 0.75 (0.20-2.82) 0.669 0.64 (0.15-2.74) 0.639
Depressants 6.70 (2.36-19.02) <0.001 4.63 (1.37-15.60) 0.013 8.50 (3.10-23.30) <0.001 7.83 (2.53-24.21) <0.001
Hallucinogenics 0.41 (0.90-1.90) 0.242  0.34 (0.06-1.73) 0.192 1.20 (0.43-3.34) 0.727 0.98 (0.30-3.18) 0.980
Polydrug 1.49 (0.69-3.21) 0.309  1.00 (0.39-2.52) 0.995 1.11 (0.49-2.53) 0.802 0.98 (0.38-2.53) 0.964
aOR: adjusted odds ratio; cOR; crude odds ratio; CI: confidence interval; ISS: Injury Severity Score.
a Mild ISS (1 to 8) as reference.
b Ajusted odds ratio using a  multinomial logistic regression adding varibles age,  sex and mechanism of injury.
Negatives: negative for drugs other than alcohol; Stimulant: positive for cocaine, amphetamines and/or methamphetamines; Depressants: positive for benzodiazepines,
opiates,  methadone and/or barbiturates; Hallucinogenic: positive for THC and/or PCP; Polydrug: positive for any combination of substances in the  above groups.
Table 3
Multivariate analysis of drugs detected and injury severity in the entire sample and by  stratums positive or negative for alcohol. Model 2: grouping all drugs other than
alcohol.
ISS moderate (9 to  15)a ISS severe (≥16)a
cOR (95%CI) p  aORb (95%CI) p  cOR (95%CI) p  aORb (95%CI) p
Entire sample
Negatives 1.00 Ref. 1.00 Ref. 1.00 Ref. 1.00 Ref.
Positives 1.24 (0.90-1.70) 0.191 1.30 (0.92-1.82) 0.135 1.32 (0.92-1.89) 0.133 1.46 (0.99-2.15) 0.057
Stratum negative for alcohol
Negatives 1.00 Ref. 1.00 Ref. 1.00 Ref. 1.00 Ref.
Positives 1.04 (0.70-1.54) 0.833 1.20 (0.79-1.82) 0.386 0.76 (0.44-1.30) 0.314 0.94 (0.53-1.70) 0.827
Stratum positive for alcohol
Negatives 1.00 Ref. 1.00 Ref. 1.00 Ref. 1.00 Ref.
Positives 1.54 (0.86-2.78) 0.146 1.11 (0.55-2.24) 0.767 1.80 (1.02-3.17) 0.041 1.64 (0.85-3.18) 0.140
aOR: adjusted odds ratio; cOR; crude odds ratio; CI: confidence interval; ISS: Injury Severity Score.
a Mild ISS (1 to 8) as reference.
b Ajusted odds ratio using a  multinomial logistic regression adding variables age, sex and mechanism of injury.
Negatives: negative for drugs other than alcohol; Positives: positive for any substance other than alcohol.
Discussion
A separate analysis of drug subgroups defined according to their
effect on the CNS allowed us to identify the specific influence of
substances with CNS-depressant effects on injury severity, espe-
cially in patients who had consumed alcohol. The results of this
study suggest that in the presence of alcohol, substances with a
CNS-depressant effect have a  strong influence on trauma severity.
We were able to  distinguish between cases in which the sub-
stance was administered as part of the trauma patient’s medical
care and cases in  which the patient had consumed the sub-
stance before the injury. This allowed us to quantify the effect of
CNS-depressant substances on severity without the need to sys-
tematically exclude patients who screened positive for opiates or
benzodiazepines, in contrast to similar studies that excluded these
patients.21,24,26
There was a high prevalence of benzodiazepine exposure in our
population of injured patients. The influence of benzodiazepines on
injury prevention is an area of growing interest. Although the exact
frequency of use of these nonprescribed substances is  not known, it
appears evident that the consumption of benzodiazepine and other
psychotropic drugs is  increasing.14,37
Particular attention should be given to motor vehicle crashes,
which can cause serious injury. In  Spain, the percentage of  traf-
fic  deaths in  which psychoactive drug use was detected alone or in
combination with alcohol and/or other drugs has doubled in the last
five years, and is  now 33.3%.33 In this connection, drugs other than
alcohol have begun to acquire particular relevance. The conclu-
sions of the European DRUID (Driving Under the Influence of  Drugs,
Alcohol and Medicines) project38 highlight the need for increased
monitoring of substances other than alcohol because their fre-
quency of use is  clearly increasing. According to  the DRUID study, in
some parts of Europe, drivers are more likely to be detected under
the influence of drugs than under the influence of alcohol. More-
over, a systematic review by Smink et al.15 found sufficient evidence
that exposure to benzodiazepines is  related to a greater risk of
accidents; although these authors recognize that more research is
needed to  clarify the relationship between the use of  these drugs
and injury severity. We  found that the effect of benzodiazepines
along with other depressants on trauma severity was very  high,
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but only in patients who had also consumed alcohol. The bio-
logical interpretation of these results is  likely to be related with
the known synergistic interaction of combinations of these drugs
in CNS depression. This effect impairs driving performance and
the  ability to react to a potential hazard by causing sedation and
increasing risk-taking behavior. Driving under the combined influ-
ence of drugs and alcohol has been found to  increase the risk of
accidents in various ways due to their influence on the driver’s
vision, awareness, perception, reaction time and concentration.29
Statistical analysis with all patients who were positive for sub-
stances in a single group (model 2) allowed us to  confirm that
pooled data analysis by  grouping drugs with opposite effects on
the CNS is a potentially misleading strategy. Therefore, some asso-
ciations between depressant drugs and injury severity may  have
been masked in previous studies.21,22,26
The profile of patients who tested positive for CNS depressant
substances was different from other profiles: female sex was more
frequent, age was substantially older, and falls were the most com-
mon  mechanism of injury. These findings reveal the need for further
analysis of the differences in  these characteristics compared to the
classic profile of individuals with trauma associated with alcohol
and other drugs, i.e. young, male, and with injuries related to  vio-
lence or traffic accidents.3,18,26,39–43 In any case, the results after
adjustment for age, sex and mechanism of injury showed that these
differences cannot be the cause of the heightened injury severity
observed in the subgroup of patients exposed to CNS-depressant
substances.
Our systematic analysis was based on all patients between 16
and 70 years of  age who were admitted to a trauma hospital,
with no other previous selection criteria. This sampling approach
decreased the possibility of selection bias. Some previous studies
were based on data obtained from national, regional or hospi-
tal trauma registries from which the authors selected records
that included available information on the exposure to drugs and
alcohol.16,19,21,22,27 If patient screening is not used consistently and
systematically, the availability of data on substance use will depend
on the physician’s decision to use or  omit the screening protocol
at the time the patient is admitted to the emergency department.
This uncertainly introduces an important source of selection bias,
because physicians may  be more likely to request substance use
testing for more severely injured patients or for those with signs of
alcohol or drug use.
Our study shares a  common limitation with previous
reports,14,17 i.e., the possible presence of false negative results for
alcohol use in patients who were not  tested for this substance at the
time of admission and who  subsequently denied alcohol consump-
tion when interviewed. Fortunately, this was not the case for the
other substances analyzed here, because all patients were screened
with appropriate laboratory tests. On  the other hand, our study
could be affected by  selection bias: we  have not included those trau-
matized patients who died at the scene of the accident due to the
extreme severity of their injuries; frequency of drug detection may
be different in these subjects. However, statistics of substance dis-
tribution among all drivers killed in  traffic accidents in  Spain show
that alcohol and/or psychotropic drugs are substances frequently
found (29.1% of drivers killed in 2015).33 Finally, another selec-
tion bias could arise because not all hospitalized trauma patients
could be screened. Nonetheless, we have no reasons to suspect an
independent association between the presence of drugs and the
probability of being screened.
Conclusions
We  detected an association between the presence of sedative
drugs and injury severity in the subgroup of trauma patients who
screened positive for alcohol consumption. We believe further
knowledge is  needed regarding the effect of drugs other than alco-
hol on trauma severity. Our results support the additional benefits
of systematic screening programs for psychoactive drug use in  all
trauma patients. The information gained from testing would not
only provide important data during clinical assessment, but would
also enable the healthcare provider to offer appropriate education,
counseling, or  other types of intervention.
What is known about the topic?
Although the effect of alcohol on the severity of the trauma
and the occurrence of complications and mortality during hos-
pitalization has been widely assessed in previous studies, the
role of drugs other than alcohol remains unclear.
What does this study add to the literature?
Our main finding is that in  patients admitted for trau-
matic injuries under the influence of depressant drugs strongly
increases the severity of  the injuries, but only in patients also
exposed to  alcohol.
Transparency declaration
The corresponding author on behalf of the other authors guar-
antee the accuracy, transparency and honesty of the data and
information contained in  the study, that no relevant information
has been omitted and that all discrepancies between authors have




All authors contributed to the design of the study, writing and
final approval of the version to be submitted. S. Cordovilla-Guardia
contributed to  the literature search, data analysis, data collection,
data interpretation and editing. P. Lardelli-Claret contributed to the
data analysis and data interpretation. R. Vilar-López contributed
to the data analysis and data interpretation. F.  López-Espuela con-
tributed in  the data interpretation. F. Guerrero-López contributed
in the data collection and data interpretation. E. Fernández-
Mondéjar contributed to the literature search, data analysis, data
interpretation and editing.
Funding
This work was supported by the Dirección General de Tráfico,
Spain [No. 0100DGT22389] and the Consejería de Salud, Junta de




The results reported here are based on work done as
part of the requirements for the PhD degree awarded to
S.  Cordovilla-Guardia et al. / Gac Sanit. 2019;33(1):4–9 9
S. Cordovilla-Guardia. We  thank K. Shashok for improving the use
of English in the manuscript.
References
1. Moore EE. Alcohol and trauma: the perfect storm. J  Trauma. 2005;59(3
Suppl):S53–6.
2. Rehm J, Gmel G,  Sempos CT,  et  al. Alcohol-related morbidity and mortality.
Alcohol Res Health. 2003;27:39–51.
3. Borges G, Cherpitel CJ, Orozco R, et al. Acute alcohol use and the risk of non-fatal
injury  in sixteen countries. Addiction. 2006;101:993–1002.
4. Rivara FP, Jurkovich GJ, Gurney JG, et  al. The magnitude of acute and chronic
alcohol abuse in trauma patients. Arch Surg. 1993;128:907–12.
5. Kool B, Ameratunga S, Jackson R.  The role of alcohol in unintentional falls among
young and middle-aged adults: a  systematic review of epidemiological studies.
Inj Prev. 2009;15:341–7.
6. Ramchand R, Marshall GN, Schell TL,  et  al. Alcohol abuse and illegal drug use
among  Los Angeles County trauma patients: prevalence and evaluation of single
item screener. J  Trauma. 2009;66:1461–7.
7. Asbridge M, Hayden JA, Cartwright JL. Acute cannabis consumption and motor
vehicle collision risk: systematic review of observational studies and meta-
analysis. BMJ. 2012;344:e536.
8. Dischinger PC, Mitchell KA, Kufera JA, et al. A longitudinal study of former
trauma center patients: the association between toxicology status and subse-
quent injury mortality. J  Trauma. 2001;51:877–84.
9. Soderstrom CA, Ballesteros MF,  Dischinger PC, et al. Alcohol/drug abuse, driving
convictions, and risk-taking dispositions among trauma center patients. Accid
Anal Prev. 2001;33:771–82.
10. Soderstrom CA, Dischinger PC, Kerns TJ, et  al. Epidemic increases in cocaine
and opiate use by trauma center patients: documentation with a  large clinical
toxicology database. J  Trauma. 2001;51:557–64.
11. Longo MC,  Hunter CE, Lokan RJ, et al. The prevalence of alcohol, cannabinoids,
benzodiazepines and stimulants amongst injured drivers and their role in driver
culpability. Part I: the prevalence of drug use in drive the drug-positive group.
Accid Anal Prev. 2000;32:613–22.
12. Longo MC,  Hunter CE, Lokan RJ, et al. The prevalence of alcohol, cannabinoids,
benzodiazepines and stimulants amongst injured drivers and their role in driver
culpability. Part II:  the relationship between drug prevalence and drug concen-
tration, and driver culpability. Accid Anal Prev. 2000;32:623–32.
13. Barrio G, Jiménez-Mejías E, Pulido J, et al. Association between cannabis use and
non-traffic injuries. Accid Anal Prev. 2012;47:172–6.
14. Cannon R, Bozeman M,  Miller KR, et al. The prevalence and impact of prescrip-
tion  controlled substance use among injured patients at a level I trauma center.
J  Trauma Acute Care Surg. 2014;76:172–5.
15. Smink BE, Egberts ACG, Lusthof KJ, et  al. The relationship between
benzodiazepine use and traffic accidents: a systematic literature review. CNS
Drugs. 2010;24:639–53.
16. Kowalenko T,  Burgess B,  Szpunar SM,  et al. Alcohol and trauma–in every age
group. Am J Emerg Med. 2013;31:705–9.
17. Yoonhee C, Jung K,  Eo E, et al. The relationship between alcohol consumption
and injury in ED trauma patients. Am J  Emerg Med. 2009;27:956–60.
18. Shih H-C, Hu S-C, Yang C-C, et  al. Alcohol intoxication increases morbidity
in  drivers involved in motor vehicle accidents. Am J Emerg Med. 2003;21:
91–4.
19. Tulloh BR, Collopy BT. Positive correlation between blood alcohol level and ISS
in  road trauma. Injury. 1994;25:539–43.
20. Watt K, Purdie DM,  Roche AM,  et  al. Injury severity: role of alcohol, substance
use and risk-taking. Emerg Med  Australas. 2006;18:108–17.
21. Draus JM,  Santos AP, Franklin GA, et al. Drug and alcohol use among adolescent
blunt trauma patients: dying to  get high. J Pediatr Surg. 2008;43:208–11.
22. Socie E, Duffy RE, Erskine T.  Substance use and type and severity of injury
among hospitalized trauma cases: Ohio, 2004-2007. J  Stud Alcohol Drugs.
2012;73:260–7.
23. Waller PF, Blow FC,  Maio RF, et al. Crash characteristics and injuries of victims
impaired by alcohol versus illicit drugs. Accid Anal Prev. 1997;29:817–27.
24. Swanson SM, Sise CB, Sise MJ,  et al. The  scourge of methamphetamine: impact
on a  level I trauma center. J Trauma. 2007;63:531–7.
25. Plurad D,  Demetriades D,  Gruzinski G,  et  al. Motor vehicle crashes: the associa-
tion of alcohol consumption with the type and severity of injuries and outcomes.
J  Emerg Med. 2010;38:12–7.
26. Demetriades D, Gkiokas G, Velmahos GC, et al. Alcohol and illicit drugs in trau-
matic  deaths: prevalence and association with type and severity of injuries.
J  Am Coll Surg. 2004;199:687–92.
27. Hadjizacharia P, Green DJ, Plurad D,  et al. Cocaine use in trauma: effect on injuries
and  outcomes. J  Trauma. 2009;66:491–4.
28. Willenberg L, Curtis K, Taylor C, et al. The variation of acute treatment costs of
trauma in high-income countries. BMC  Health Serv Res. 2012;12:267.
29. Behnood A, Mannering FL.  The effects of drug and alcohol consump-
tion on  driver-injury severities in single-vehicle crashes. Traffic Inj  Prev.
2017;18:456–62.
30. Babor TF, McRee BG, Kassebaum PA, et al. Screening, Brief Intervention, and
Referral to Treatment (SBIRT): toward a public health approach to the  manage-
ment of substance abuse. Subst Abus. 2007;28:7–30.
31. Bush DM. The U.S. Mandatory Guidelines for Federal Workplace Drug Test-
ing Programs: current status and future considerations. Forensic Sci Int.
2008;174:111–9.
32. Corporation PB.  StatusFirstTM DOA 10. 2000 (Accessed 2016 Apr 17.) Available
at: http://www.lifesignmed.com/sites/default/files/StatusFirst DOA Package
Insert.pdf.
33. Instituto Nacional de Toxicología y Ciencias Forenses. MEMORIA 2015. 2015.
(Accessed 2017 Jun  3.) Available at: https://www.administraciondejusticia.
gob.es/paj/PA WebApp SGNTJ NPAJ/descarga/MEMORIA%25INTCF%252015.
pdf?idFile=2486f6d0-1c77-48e5-8d64-d26e47e1b582
34. Watson PE, Watson ID, Batt  RD. Prediction of blood alcohol concentra-
tions  in human subjects. Updating the Widmark Equation. J  Stud Alcohol.
1981;42:547–56.
35. Gennarelli TA, Wodzin E. Abbreviated Injury Scale 2005. Update 2008.
Barrington, IL: Association for the Advancement of Automotive Medicine; 2008.
36.  Baker SP, O’Neill B, Haddon W, et al. The  injury severity score: a  method
for describing patients with multiple injuries and evaluating emergency care.
J  Trauma. 1974;14:187–96.
37. Novak SP,  Håkansson A, Martínez-Raga J, et al. Nonmedical use of prescription
drugs in the European Union. BMC  Psychiatry. 2016;16:274.
38. Horst S, Markus S, Raschid U, et al. DRUID Final Report: work performed, main
results  and recommendations. (Accessed 1  November 2016.) Available at:
http://www.druid-project.eu/Druid/EN/Dissemination/downloads and links/
Final  Report.html?nn=613804
39. Vitale S, van de Mheen D. Illicit drug use and injuries: a  review of emergency
room  studies. Drug Alcohol Depend. 2006;82:1–9.
40. Cordovilla-Guardia S, Vilar-López R, Lardelli-Claret P, et al. Ingreso en cuidados
intensivos por un traumatismo relacionado con el consumo de alcohol o  dro-
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